NCT06610110View on ClinicalTrials.gov

Caffeine, CYPA12 and Resistance Exercise

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
CYP1A2 PolymorphismCaffeine and Resistance Exercise
Interventions
DIETARY_SUPPLEMENT

Caffeine

Acute caffeine intake (3 mg/kg)

DIETARY_SUPPLEMENT

Placebo

Placebo (3 mg/kg maltodextrin)

Trial Locations (2)

28805

RECRUITING

Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá, Alcalá de Henares

Unknown

RECRUITING

Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá, Alcalá de Henares

All Listed Sponsors
collaborator

University of Alcala

OTHER

collaborator

iSanidad+Herbalife

UNKNOWN

lead

Alberto Pérez-López

OTHER